Source: Designer Surgeries
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Dental centre operator Pacific Smiles Group (PSQ) has entered a trading halt as it finalises arrangements for a $20 million financing
  • An initial $15 million will be raised pursuant to a jointly underwritten placement with Bell Potter Securities and Wilsons Corporate Finance
  • A further $5 million will be raised according to a share purchase plan to eligible shareholders in Australia and New Zealand
  • The proceeds will be used primarily to expand PSQ’s network with 15 new dental centres
  • Pacific Smile Group last traded at $2.70 per share on Monday, March 1, and is expected to remain suspended from trading until tomorrow

Dental centre operator Pacific Smiles Group (PSQ) has entered a trading halt as it finalises arrangements for a $20 million financing.

An initial $15 million will be raised pursuant to a jointly underwritten placement with Bell Potter Securities and Wilsons Corporate Finance. The new shares in Pacific Smiles will be issued at $2.60 per share, representing a 3.7 per cent discount compared to the company’s closing price of $2.70 on March 1.

A share purchase plan to eligible shareholders in Australia and New Zealand will then seek to raise a further $5 million. Shareholders of Pacific Smiles registered as of March 1 will be able to purchase up to $30,000 worth of shares, also at $2.60 each.

All of the shares issued under both the placement and share purchase plan will be eligible for Pacific Smiles’ recently declared dividend of 2.4 cents per share.

The company said that while its new centre openings were reduced during the height of the COVID-19 pandemic, it is now in a strong position to grow its network with 15 new centres in the 2021 financial year.

It’s part of the company’s target to roll out at least 20 new centres each year. However, this target remains subject to specific locations that become available, leasing terms and the availability of dental practitioners.

“We believe this is the right time to strengthen our balance sheet as the Company prepares for the next phase of its growth,” said Phil McKenzie, CEO of Pacific Smiles Group.

“We see plenty of opportunity in the market, and while we will continue to be very disciplined with capital allocation, we believe positioning the Company to accelerate our rollout is a logical move,” he added.

Upon completion of the financing, Pacific Smiles is expected to have roughly $18 million in net cash — before financing costs — and $37 million in available debt facilities.

Pacific Smiles Group last traded at $2.70 per share on Monday, March 1, and is expected to remain suspended from trading until tomorrow.

PSQ by the numbers
More From The Market Online
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…